Merle Griff, Ph.D.
Equibles does not estimate personal net worth.
About Merle Griff, Ph.D.
Earlier roles on record: CEO at AnTix Holdings, Inc. (IMTH) until April 18, 2024. AnTix Holdings, Inc. reported in an 8-K filed April 22, 2024 that Merle Griff, Ph.D. was terminated as CEO, effective April 18, 2024.
“On April 18, 2024, Innovative MedTech, Inc. (the "Company") terminated Merle Griff, PhD., as the Company's CEO, and Michael Friedman, the Company's President and CFO, was appointed as CEO of the Company.”
Affiliation history
-
2022-05-24–2024-04-18